Recurrent Prostate Study

Study Features FACBC Advanced Imaging Technology

April 29, 2015

Have you previously had surgery to treat prostate cancer, but think the cancer has returned? Has your doctor recommended radiation therapy as the next step in your care?

A voluntary research study is being conducted to help men with recurring prostate cancer by using advanced imaging technology called FACBC to guide radiotherapy and determine the best possible course of treatment. This study would be added as an extra layer in your ongoing cancer treatment. We are looking for patients to participate in this clinical trial.

"By participating in this study, patients may have the opportunity to have an FACBC scan. The precision of this type of scan could help guide more effective treatment for patients whose cancer has returned," says Ashesh Jani, MD, radiation oncologist and principal investigator.

Participants must meet specific eligibility criteria:

  • You are over 18 years of age.
  • You had surgery (prostatectomy) to treat your prostate cancer.
  • Your doctor suspects that the cancer has returned (as indicated by a rising PSA).
  • Radiation therapy is now being considered as the next step in your care.

The trial is open at these locations: Winship Cancer Institute on the Clifton Road campus, Winship at Emory University Hospital Midtown, Winship at Emory Saint Joseph’s Hospital and Georgia Cancer Center for Excellence at Grady.

For more information or to enroll, contact Ashesh Jani, MD, at (404) 778-3827 or abjani@emory.edu.


Learn more about comprehensive prostate treatment at Winship Cancer Institute.